BioCryst Pharmaceuticals Inc (BCRX)
6.47
-0.10
(-1.52%)
USD |
NASDAQ |
May 31, 16:00
6.435
-0.04
(-0.54%)
After-Hours: 20:00
BioCryst Pharmaceuticals Accounts Payable (Quarterly): 11.91M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.91M |
December 31, 2023 | 20.89M |
September 30, 2023 | 10.57M |
June 30, 2023 | 13.89M |
March 31, 2023 | 6.254M |
December 31, 2022 | 14.36M |
September 30, 2022 | 8.622M |
June 30, 2022 | 12.02M |
March 31, 2022 | 13.88M |
December 31, 2021 | 27.81M |
September 30, 2021 | 19.69M |
June 30, 2021 | 10.09M |
March 31, 2021 | 13.53M |
December 31, 2020 | 18.71M |
September 30, 2020 | 11.62M |
June 30, 2020 | 9.354M |
March 31, 2020 | 10.06M |
December 31, 2019 | 13.99M |
September 30, 2019 | 10.08M |
June 30, 2019 | 8.298M |
March 31, 2019 | 6.935M |
December 31, 2018 | 7.769M |
September 30, 2018 | 7.911M |
June 30, 2018 | 4.122M |
March 31, 2018 | 3.588M |
Date | Value |
---|---|
December 31, 2017 | 6.337M |
September 30, 2017 | 4.603M |
June 30, 2017 | 1.844M |
March 31, 2017 | 5.433M |
December 31, 2016 | 4.269M |
September 30, 2016 | 2.76M |
June 30, 2016 | 5.051M |
March 31, 2016 | 7.691M |
December 31, 2015 | 9.307M |
September 30, 2015 | 3.782M |
June 30, 2015 | 3.822M |
March 31, 2015 | 5.307M |
December 31, 2014 | 2.849M |
September 30, 2014 | 2.266M |
June 30, 2014 | 2.36M |
March 31, 2014 | 1.352M |
December 31, 2013 | 4.174M |
September 30, 2013 | 1.241M |
June 30, 2013 | 0.989M |
March 31, 2013 | 1.073M |
December 31, 2012 | 3.974M |
September 30, 2012 | 2.293M |
June 30, 2012 | 3.328M |
March 31, 2012 | 2.062M |
December 31, 2011 | 2.497M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
6.254M
Minimum
Mar 2023
27.81M
Maximum
Dec 2021
13.28M
Average
11.97M
Median
Accounts Payable (Quarterly) Benchmarks
Integra Lifesciences Holdings Corp | 94.40M |
Nortech Systems Inc | 15.22M |
Novavax Inc | 57.72M |
SINTX Technologies Inc | 0.448M |
Allogene Therapeutics Inc | 5.779M |